The inhibition of GSK-3β by its shRNA significantly reduced the role of MEG3 in regulating β-catenin and in promoting the invasion of retinoblastoma cells [56], suggesting that the GSK-3β protein is an important intermediator for the MEG3 functions. This evidence concerns the gene MEG3 and retinoblastoma.